Enhanced Immunogenicity of B Cell Lymphoma Genetically Engineered to Express Both B7-1 and Interleukin-12
Year: 1997
Type: article
Source: Human Gene Therapy
Institutions: University of Toronto, Sunnybrook Health Science Centre
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2005584275
